Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
generic drugs
4
×
life sciences
novartis
4
×
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
deals
detroit blog main
detroit top stories
gene therapy
indiana blog main
indiana top stories
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
alzheimer's disease
biogen
cancer
chemotherapy
crispr
crispr therapeutics
What
bio
drug
roundup
life
new
acquisitions
albert
approval
bails
biggest
biogen’s
biopharmaceutical
biotech
bourla
brand
bridgebio
capital
car
ceo
companies
company
convo
crispr
develop
driving
drugs
earlier
emerges
failures
firm
future
good
grab
headlines
healthcare
history
ichnos
imports
improved
industry
Language
unset
unknown
Current search:
" generic drugs "
×
novartis
×
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
